The in silico analysis of PER2 mRNA expression in 369 HCC samples and 50 normal liver tissue samples revealed no significative difference in PER2 mRNA expression between tumor and normal tissues [Figure 1A], nor across HCC samples at different stages [Figure 1B] evaluated according to the American Joint Committee on Cancer (AJCC) TNM system. This evidence concerns the gene PER2 and neoplasm.